Last reviewed · How we verify
Injection of Secretome-MSCs — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Injection of Secretome-MSCs (Injection of Secretome-MSCs) — Stem Cell and Cancer Research Indonesia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Injection of Secretome-MSCs TARGET | Injection of Secretome-MSCs | Stem Cell and Cancer Research Indonesia | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Injection of Secretome-MSCs CI watch — RSS
- Injection of Secretome-MSCs CI watch — Atom
- Injection of Secretome-MSCs CI watch — JSON
- Injection of Secretome-MSCs alone — RSS
Cite this brief
Drug Landscape (2026). Injection of Secretome-MSCs — Competitive Intelligence Brief. https://druglandscape.com/ci/injection-of-secretome-mscs. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab